Literature DB >> 6340620

Captopril-associated neutropenia. Who is at risk?

R A Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6340620

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  10 in total

Review 1.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

2.  Low-dose enalapril in severe chronic heart failure.

Authors:  C G Brilla; B Krämer; H M Hoffmeister; W Müller-Schauenburg; T Risler; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

Review 3.  Perindopril safety and tolerance in at-risk patients.

Authors:  S Brichard; A E Lambert
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

5.  Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21.

Authors:  M M Gleason; J S Roloff; S E Cyran; H S Weber; B G Baylen; J L Myers
Journal:  Pediatr Cardiol       Date:  1993-10       Impact factor: 1.655

6.  [Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].

Authors:  J Schrader; G Schoel; F Scheler
Journal:  Klin Wochenschr       Date:  1986-08-01

Review 7.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

8.  Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients.

Authors:  C Speirs; F Wagniart; L Poggi
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

Review 9.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 10.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.